Navigation Links
AccuVein Vein Illuminator Receives European CE Mark
Date:8/4/2009

COLD SPRING HARBOR, N.Y., Aug. 4 /PRNewswire/ -- AccuVein LLC, maker of the AV300, the world's first hand-held, non-contact vein illumination device, announced today that its medical device now carries a CE Mark, enabling the Company to commence European sales of AccuVein's AV300.

"Receiving approval to ship the AV300 to Europe is an important step in bringing this beneficial device to healthcare practitioners around the globe," said Stephen P. Conlon, President of AccuVein. "Furthermore, Europe provides a significant growth opportunity for AccuVein allowing us to build upon our successful launch in the United States."

AccuVein recently achieved an International Organization for Standardization (ISO) 13485 Certification, acknowledging that its quality management processes meet international standards.

The AccuVein AV300 helps advance patient care in a variety of settings by assisting healthcare professionals in locating the vein quickly for blood draws, intravenous lines and delivery of medications. Weighing only 10 ounces, the AV300 uses point-and-click technology - the healthcare professional simply presses a button and positions the device above the patient's skin to display a map on the skin of underlying veins. With a range of hands-free options, the AV300 can quickly switch between a hand-held and hands-free mode, freeing the practitioner's hands to perform the venipuncture.

For more information on the AccuVein AV300, please visit www.AccuVein.com.

About AccuVein

AccuVein applies advanced technologies to important healthcare challenges. Their innovative AV300 allows practitioners to see a map on the patient's skin of the position of peripheral veins, helping caregivers locate these veins while they perform the most common invasive medical procedure - venipuncture. Built using AccuVein's expertise in medical device miniaturization and user-intuitive design, the AV300 is the world's first portable, non-contact vein illumination solution. With more than a dozen patents filed worldwide, AccuVein demonstrates an ongoing commitment to invest in improving patient care and patient satisfaction.

For more information on the AccuVein AV300, please visit www.AccuVein.com.

    Contacts:

    For Media Inquiries:
    Jennifer Seelin
    Makovsky + Company
    212-508-9610
    jseelin@makovsky.com

    For Sales Inquiries:
    Joe McCormick
    AccuVein LLC
    888-909-8888
    joe.mccormick@accuvein.com


'/>"/>
SOURCE AccuVein LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AccuVein Achieves Quality System Milestone
2. AccuVein AV300, First Portable Vein Illumination Device, Now Available on GSA Schedule
3. Video: AccuVein Launches First Portable, Non-Contact Vein Illumination Device
4. CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology
5. Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG
6. Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)
7. Hanger Orthopedic Group, Inc. Receives Upgrade From Moodys Investors Service
8. PharmaForce Inc. Receives FDA Approval for First Generic of Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP
9. Caldwell College Receives Approval to Launch First Ph.D. for Applied Behavior Analysis-Autism Treatment in New Jersey
10. Pitt receives $13.4 million NIH grant to create virtual models for epidemics
11. Janet Rowley, MD, A Researcher Funded by The Leukemia & Lymphoma Society, Receives Presidential Medal of Freedom
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: